Our experience with the treatment of malignant liver tumours

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F02%3A00007696" target="_blank" >RIV/00216224:14110/02:00007696 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

čeština

Název v původním jazyce

Our experience with the treatment of malignant liver tumours

Popis výsledku v původním jazyce

In complex oncologic treatment, liver resections play a very important role. Their techique is elaborated. Nowadays, the development focuses on miniinvasive treatment modalities and improvement of hemotherapy regimens. The aim of the paper is the presentation of experience of our surgical department. In the time period from 1988 to 2001, 198 patients with malignant liver tumours were operated on in the 2nd Department of Surgery in Brno. There were 132 resections. In 58 patients, a catheter for regionalchemotherapy was inserred, either as a palliative intervention, or for adjuvant chemotherapy after resection. In the last 4 years, the in-hospital mortality rate after liver resections was 2%. The median survival of patents after resection of primary liver tumours was 36 months, after resection of liver metastases 34 months, and among pareints treated with regional chemotherapy 17 months.

Název v anglickém jazyce

Our experience with the treatment of malignant liver tumours

Popis výsledku anglicky

In complex oncologic treatment, liver resections play a very important role. Their techique is elaborated. Nowadays, the development focuses on miniinvasive treatment modalities and improvement of hemotherapy regimens. The aim of the paper is the presentation of experience of our surgical department. In the time period from 1988 to 2001, 198 patients with malignant liver tumours were operated on in the 2nd Department of Surgery in Brno. There were 132 resections. In 58 patients, a catheter for regionalchemotherapy was inserred, either as a palliative intervention, or for adjuvant chemotherapy after resection. In the last 4 years, the in-hospital mortality rate after liver resections was 2%. The median survival of patents after resection of primary liver tumours was 36 months, after resection of liver metastases 34 months, and among pareints treated with regional chemotherapy 17 months.

Druh

D - Stať ve sborníku

CEP obor

FJ - Chirurgie včetně transplantologie

OECD FORD obor

—

Projekt

—

Návaznosti

Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2002

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

Mini-Invasive approach to Cancer

ISBN

—

ISSN

—

e-ISSN

—

Počet stran výsledku

1

Strana od-do

134

Název nakladatele

European Association for Endoscopic Surgery

Místo vydání

Lisboa

Místo konání akce

Lisboa

Datum konání akce

2. 6. 2002

Typ akce podle státní příslušnosti

WRD - Celosvětová akce

Kód UT WoS článku

—